Breaking News Instant updates and real-time market news.

SCHW

Charles Schwab

$39.75

0.29 (0.73%)

10:25
10/18/19
10/18
10:25
10/18/19
10:25

Charles Schwab to host business news update conference call

President & CEO Bettinger and EVP & CFO Crawford hold a 2019 Fall business update conference call to be held on October 18 at 11 am. Webcast Link

  • 18

    Oct

  • 27

    Oct

SCHW Charles Schwab
$39.75

0.29 (0.73%)

10/14/19
SBSH
10/14/19
NO CHANGE
SBSH
Citi opens '30-Day Negative Catalyst Watch' on Waddell & Reed
Citi analyst William Katz opened a "30-Day Negative Catalyst Watch" for Sell-rated Waddell & Reed (WDR) and initiated a "90-Day Positive Catalyst Watch" on Buy-rated Carlyle Group (CG). He also initiated a "Persistent Existentialism" pair trade, or overweight Charles Schwab (SCHW) and underweight TD Ameritrade (AMTD), a stock he downgraded this morning to Sell from Neutral. Into the Q3 earnings season, the analyst lowered his 12-month price targets for the Brokers and Asset Managers to reflect a combination of lower target multiples and reduced earnings prospects.
10/09/19
DBAB
10/09/19
NO CHANGE
DBAB
Hold
Deutsche sees 'major' M&A as potential path for E-Trade, Ameritrade
Charles Schwab's (SCHW) move to cut trade commissions to zero is likely to spur business model changes at TD Ameritrade (AMTD) and E-Trade Financial (ETFC), Deutsche Bank analyst Brian Bedell tells investors in a research note. Instead of managing "persistent" revenue declines, management teams should seek to leverage their strong operating platforms and loyal customer base into a more diversified retail financial service offering that includes online banking, digital wealth management and investment advisory, argues the analyst. This may require "major" M&A for E-Trade and Ameritrade, while Schwab can likely augment its wider range of offerings organically or via smaller bolt on deals, says Bedell. He still views Ameritrade as the "most efficient acquirer" of E-Trade, but finds it no longer clear that the combination "would create a broad enough financial services offering for the new revenue paradigm." One alternative idea could be an E-Trade combination with a digital banking and wealth management platform, says the analyst, who analyzed a potential merger with Goldman Sachs (GS). Bedell also wonders if Ameritrade will eventually explore strategic alternatives or if 43% owner TD Bank (TD) will eventually seek to acquire a much larger controlling stake in the company.
10/09/19
JEFF
10/09/19
NO CHANGE
Target $43
JEFF
Buy
Jefferies says Schwab best positioned discount broker after commission cuts
Jefferies analyst Daniel Fannon said following last week's commission cut announcements that he views Charles Schwab (SCHW) as the best positioned discount broker to capitalize on trends in the industry toward fee-based advice and advisors going independent. Interest rates will "push around near-term profitability," but he believes Schwab's net new asset growth is poised to remain industry-leading, Fannon said. Among publicly traded companies in the space, Fannon still views E-Trade (ETFC) as the most likely M&A candidate, he added. Given the recent commission cuts, he lowered his price target on Schwab shares to $43 from $49, lowered his price target on E-Trade to $44 from $54 and cut his price target on TD Ameritrade (AMTD) to $36 from $55. Fannon has Buy ratings on the first two stocks mentioned and a Hold rating on TD Ameritrade.
10/03/19
10/03/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Market Perform from Outperform at JMP Securities with analyst Joseph Osha saying that while the figures were not "significantly far off" from consensus, delivery unit growth was in low-single-digits with no indications of operational issues. 2. Charles Schwab (SCHW) and E-Trade (ETFC) downgraded to Market Perform from Outperform at Wells Fargo while TD Ameritrade (AMTD) was downgraded to Underperform from Outperform. 3. Teligent (TLGT) downgraded to Market Perform from Outperform at Raymond James with analyst Elliot Wilbur citing the announcement of a strategic review of assets that are non-core to the company's long-term strategy. 4. Insulet (PODD) downgraded to Neutral from Buy at Guggenheim with analyst Chris Pasquale saying while he continues to see the company being competitively well positioned, he now sees the risk/reward as less attractive. 5. Delta Air Lines (DAL) downgraded to Neutral from Buy at Buckingham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:13
11/12/19
11/12
08:13
11/12/19
08:13
Hot Stocks
scPharmaceuticals expects 2019 cash, cash equivalents $65M-$70M »

Based on its current…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCPH

scPharmaceuticals

$5.26

0.11 (2.14%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Earnings
scPharmaceuticals reports Q3 EPS (31c), consensus (45c) »

"We continue to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Hot Stocks
Amarin jumps as FDA posts documents for Vascepa advisory committee meeting »

Shares of Amarin (AMRN)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

CBMG

Cellular Biomedicine

$17.86

0.11 (0.62%)

08:12
11/12/19
11/12
08:12
11/12/19
08:12
Downgrade
Cellular Biomedicine rating change  »

Cellular Biomedicine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCNX

Vaccinex

$5.05

0.19 (3.91%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Earnings
Vaccinex reports Q3 revenue $404,000, consensus 30,000 »

"The highlight of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

, BIOX

Bioceres

$5.70

-0.2 (-3.39%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Verdeca receives approval of HB4 drought and herbicide tolerant soybeans »

Verdeca, a joint venture…

RKDA

Arcadia Biosciences

$4.08

-0.015 (-0.37%)

BIOX

Bioceres

$5.70

-0.2 (-3.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NH

NantHealth

$0.70

0.008 (1.16%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
NantHealth reports FDA marketing authorization of Omics Core »

NantHealth reported FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:11
11/12/19
11/12
08:11
11/12/19
08:11
Hot Stocks
Amarin soars after FDA posts briefing docs ahead of Nov. 14 panel »

Shares of Amarin are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

SWTX

SpringsWorks Therapeutics

$18.42

-0.1 (-0.54%)

08:10
11/12/19
11/12
08:10
11/12/19
08:10
Earnings
SpringsWorks Therapeutics reports Q3 EPS ($1.77), consensus (47c) »

"The third quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNE

Clean Energy

$2.23

-0.01 (-0.45%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Earnings
Clean Energy reports Q3 EPS (2c), consensus (2c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

HON

Honeywell

$180.73

-0.48 (-0.26%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Honeywell Process Solutions selected by Kuwait Integrated Petroleum Industries »

Honeywell announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:09
11/12/19
11/12
08:09
11/12/19
08:09
Hot Stocks
Cellectar Biosciences expects cash to fund operations into 1Q21 »

As of September 30, 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.30

-0.095 (-6.81%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Earnings
Cellectar Biosciences reports Q3 EPS (42c), consensus (38c) »

"We continue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.05

-0.02 (-1.87%)

08:08
11/12/19
11/12
08:08
11/12/19
08:08
Hot Stocks
Moleculin Biotech receives FDA approval for IND of WP1066 »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Hot Stocks
LogicBio Therapeutics expects cash to fund operations into 2021 »

Cash, cash equivalents…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOGC

LogicBio Therapeutics

$9.49

0.09 (0.96%)

08:07
11/12/19
11/12
08:07
11/12/19
08:07
Earnings
LogicBio Therapeutics reports Q3 EPS (48c), consensus (46c) »

"This has been a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$16.90

-0.58 (-3.32%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin jumps 7% to $18.13…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 28

    Dec

MPAA

Motorcar Parts

$19.96

-0.66 (-3.20%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Earnings
Motorcar Parts reports Q2 adj. EPS 68c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

FATE

Fate Therapeutics

$14.49

-0.09 (-0.62%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Initiation
Fate Therapeutics initiated  »

Fate Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$38.33

0.17 (0.45%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
Legg Mason reports AUM of $791.0B as of October 31 »

Legg Mason reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$39.21

1.09 (2.86%)

, VIA

Viacom

$26.40

0.87 (3.41%)

08:06
11/12/19
11/12
08:06
11/12/19
08:06
Hot Stocks
CBS, Viacom merger expected to close in early December »

On August 13, CBS (CBS)…

CBS

CBS

$39.21

1.09 (2.86%)

VIA

Viacom

$26.40

0.87 (3.41%)

VIAB

Viacom

$23.46

0.71 (3.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 09

    Dec

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Conference/Events
Craig-Hallum to hold a conference »

10th Annual Craig-Hallum…

MJARF

MJardin Group

$0.00

(0.00%)

08:05
11/12/19
11/12
08:05
11/12/19
08:05
Hot Stocks
MJardin Group announces partnership with Robes Inc. »

MJardin Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Nov

RUBY

Rubius Therapeutics

$10.91

-0.13 (-1.18%)

, SYBX

Synlogic

$2.28

-0.015 (-0.66%)

08:04
11/12/19
11/12
08:04
11/12/19
08:04
Hot Stocks
Rubius Therapeutics appoints Maiken Keson-Brookes as CLO »

Rubius Therapeutics…

RUBY

Rubius Therapeutics

$10.91

-0.13 (-1.18%)

SYBX

Synlogic

$2.28

-0.015 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

PBI

Pitney Bowes

$4.95

-0.14 (-2.75%)

08:04
11/12/19
11/12
08:04
11/12/19
08:04
Hot Stocks
Pitney Bowes announces partnership with Luxer One »

Pitney Bowes announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.